Clinical

Dataset Information

0

Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients


ABSTRACT: This is a Phase Ib study to evaluate the safety and preliminary anti-tumor activity of pembrolizumab in combination with pemetrexed with or without oxaliplatin in patients with chemo-refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC) without any further standard treatment options.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2280743 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2246662 | ecrin-mdr-crc
2023-10-01 | E-MTAB-8288 | biostudies-arrayexpress
2023-02-17 | GSE225078 | GEO
| 2175941 | ecrin-mdr-crc
2013-10-28 | GSE50692 | GEO
2024-10-28 | GSE261380 | GEO
2013-10-28 | E-GEOD-50692 | biostudies-arrayexpress
2024-10-10 | GSE266079 | GEO
2024-10-11 | GSE273798 | GEO
2021-08-31 | GSE181815 | GEO